Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial

Código QR

Homologous recombination deficiency and glycolysis‐related pathway in adjuvant chemotherapy for triple‐negative breast cancer: A genomic landscape and biomarker assessment of the PATTERN trial

Guardado en:

Detalles Bibliográficos
Autores principales:	Si‐Yuan Zhu, Ding Ma, Fu‐Gui Ye, Zhi‐Ming Shao, Ke‐Da Yu
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c09effbbe6a449aaa0d3e46312f8c2fc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pan-cancer landscape of homologous recombination deficiency
por: Luan Nguyen, et al.
Publicado: (2020)

Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
por: Neha Chopra, et al.
Publicado: (2020)

FREQUENCY OF PATHOLOGICAL COMPLETE RESPONSE (PCR) IN PATIENTS OF TRIPLE NEGATIVE BREAST CANCER AFTER NEO-ADJUVANT CHEMOTHERAPY
por: Zeeshan Ahmed Khan Niazi, et al.
Publicado: (2021)

Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies
por: Nina Radosevic-Robin, et al.
Publicado: (2021)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
por: Maria Vittoria Dieci, et al.
Publicado: (2021)

Locoregional recurrence of triple-negative breast cancer: effect of type of surgery and adjuvant postoperative radiotherapy
por: Bayoumi Y, et al.
Publicado: (2014)

Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
por: Jason J. Pitt, et al.
Publicado: (2018)

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
por: Ozge Saatci, et al.
Publicado: (2020)

Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
por: Hao Huang, et al.
Publicado: (2021)

Current advances in biomarkers for targeted therapy in triple-negative breast cancer
por: Fleisher B, et al.
Publicado: (2016)

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
por: Kai Miao, et al.
Publicado: (2020)

Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
por: Pepijn M. Schoonen, et al.
Publicado: (2017)

GSA: an independent development algorithm for calling copy number and detecting homologous recombination deficiency (HRD) from target capture sequencing
por: Dongju Chen, et al.
Publicado: (2021)

The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
por: Zilin Zhang, et al.
Publicado: (2021)

THE MAIN PARAMETERS OF CELLULAR IMMUNITY IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER: RELATIONSHIP WITH EFFICIENCY OF CHEMOTHERAPY
por: A. I. Chertkova, et al.
Publicado: (2018)

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
por: Maitri Kalra, et al.
Publicado: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Bingqing Xia, et al.
Publicado: (2021)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Corey Speers, et al.
Publicado: (2017)

Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
por: da Silva JL, et al.
Publicado: (2021)

Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population
por: Chia-Hsin Wu, et al.
Publicado: (2021)

Author Correction: Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features
por: Jason J. Pitt, et al.
Publicado: (2019)

Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.
por: Troels K H Scheel, et al.
Publicado: (2013)

Quantitative proteomic landscape of metaplastic breast carcinoma pathological subtypes and their relationship to triple-negative tumors
por: Sabra I. Djomehri, et al.
Publicado: (2020)

PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1
por: Rimma Belotserkovskaya, et al.
Publicado: (2020)

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
por: Miklos Diossy, et al.
Publicado: (2021)

Dynamically Accumulating Homologous Recombination Deficiency Score Served as an Important Prognosis Factor in High-Grade Serous Ovarian Cancer
por: Rongjia Su, et al.
Publicado: (2021)

Gastroesophageal junction adenocarcinoma displays abnormalities in homologous recombination and nucleotide excision repair
por: Dewalt RI, et al.
Publicado: (2014)

Targeting mTOR and DNA repair pathways in residual triple negative breast cancer post neoadjuvant chemotherapy
por: Kartik Anand, et al.
Publicado: (2021)

Prognostic Influence of Residual Tumor-Infiltrating Lymphocyte Subtype After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jesse Lopes da Silva, et al.
Publicado: (2021)

Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: Bing Jiang, et al.
Publicado: (2021)

Targeted Inter-Homologs Recombination in Arabidopsis Euchromatin and Heterochromatin
por: Shdema Filler-Hayut, et al.
Publicado: (2021)

Impact of Homologous Recombination on the Evolution of Prokaryotic Core Genomes
por: Pedro González-Torres, et al.
Publicado: (2019)

Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Pairwise and Network Meta-Analysis of Pathological Complete Response
por: Zeng-Jie Weng MM, et al.
Publicado: (2021)

Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
por: Zhi-Ling Li, et al.
Publicado: (2020)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
por: Romualdo Barroso-Sousa, et al.
Publicado: (2021)

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
por: Wang X, et al.
Publicado: (2021)

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis
por: Yuanfang Xin, et al.
Publicado: (2021)

Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231
por: Christian Garbar, et al.
Publicado: (2017)

A ‘parameiosis’ drives depolyploidization and homologous recombination in Candida albicans
por: Matthew Z. Anderson, et al.
Publicado: (2019)

Homologous recombination is stimulated by a decrease in dUTPase in Arabidopsis.
por: Emeline Dubois, et al.
Publicado: (2011)